PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Mok, Chi Chiu
TI  - Denosumab May Warrant Further Testing in Patients Receiving Long-Term GC Therapy
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 19--20
VI  - 14
IP  - 17
4099  - http://mdc.sagepub.com/content/14/17/19.short
4100  - http://mdc.sagepub.com/content/14/17/19.full
AB  - Although glucocorticoids (GCs) are a backbone of the treatment of rheumatic diseases, they are the major cause of secondary osteoporosis and are associated with increased fracture rate and decreased bone quality. This article discusses outcomes from Denosumab in Current Users of Bisphosphonates for Glucocorticoid-Induced Osteoporosis [NCT01465568].